Adaptation of the Guidance document Description of document protection HMV4

18.02.2019

Explanation regarding the duration of document protection requested subsequently (innovative indication, purely paediatric application, Orphan Drug / MUMS status)

The new version of the affected Guidance document will enter into force immediately.